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SUMMARY 
Heterologous (rabbit) anti-lymphocyte sera, raised by immunization with rat 
lymph node, thymic and splenic lymphocytes, have been shown to be of equal 
potency in suppressing experimental allergic thyroiditis in rats sensitized to 
allogeneic thyroid-adjuvant emulsion and pertussis vaccine. 
INTRODUCTION 
In a recent study (Ono et al., 1969) the relative immunosuppressive qualities of heterologous 
(rabbit) anti-lymphocyte (ALS) sera raised with rat lymphocytes from lymph nodes, thymus 
and spleen were determined. Using a test system of heterotopic cardiac transplantation, no 
inherent differences in the efficiency of these antisera could be detected. 
In the present communication, an extension of these investigations is reported. Experi-
mental allergic thyroiditis was produced in rats by the method of Paterson & Drobish 
(1968), and the various rabbit antisera were evaluated for their ability to prevent the develop-
ment of this iatrogenic disease. 
MA TERIALS AND METHODS 
Preparation of antisera 
The details of the ALS preparation have been previously reported (Ono et al., 1969). In 
brief, the three kinds of lymphocytes were removed from the lymph nodes, thymuses and 
spleens of inbred Fischer rats (purchased from Charles River Breeding Laboratories, Inc., 
Wilmington, Massachusetts), and given intravenously once a week for 4 weeks to New 
Zealand White rabbits to a total dose of approximately 3 x 108 cells. Blood was collected 
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by cardiac puncture 7 days after the fourth injection. Six rabbits contributed to a pool of 
each kind of antiserum. Before administration, the antisera were decomplemented by heating 
at 56°C for 30 min and then absorbed with rat platelets and rat red blood cells. For control 
studies, normal rabbit serum was collected and treated in the same way except that it was 
not submitted to absorption procedures. 
After completion of the absorptions, the three antisera had similar Iymphoagglutinin 
(l: 1000), thymoagglutinin (l: 1000) and lymphotoxicity (1 : 512) titres. 
Production of thyroiditis 
Commercially available Wistar and Sprague-Dawley frozen thyroid tissue (Pel-Freeze, 
Rogers, Arkansas) was thawed and homogenized in an equal volume of normal saline. 
TABLE 1. Effect of various anti-sera on experimental allergic thyroiditis in 
the rat 
Histological evidence 
Group No. of rats Sensitization (treatment) of thyroiditis present 
(No. of rats) 
A Ten Thyroid-adjuvant Ten 
emulsion (saline) 
B Ten Thyroid-adjuvant One 
emulsion (LNLAS) 
C Ten Thyroid-adjuvant None 
emulsion (TLAS) 
D Ten Thyroid-adjuvant None* 
emulsion (SLAS) 
E Six Thyroid-adjuvant Five 
emulsion (NRS) 
F Ten Saline-adjuvant None 
emulsion (none) 
LNLAS, lymph node lymphocyte anti-serum; TLAS, thymus lympho-
cyte anti-serum; SLAS, spleen lymphocyte anti-serum; NRS, normal 
rabbit serum. 
* One animal died during course of experiment. 
The homogenate was emulsified with an equal volume of Freund's complete adjuvant 
(Difco Laboratories, Detroit, Michigan), and male 190-200-g Wistar-Furth rats (Micro-
biological Associates, Bethesda, Maryland) were injected once with the suspension. The 
dose was 0·1 ml into the plantar surface of the right, hind foot. At the same time 0·1 ml of a 
concentrated pertussis vaccine (supplied by Dr H. B. Devlin, Parke, Davis and Company, 
Detroit, Michigan) was injected into the dorsal surface of the same foot. In one group of 
control rats (Group F, Table 1) pertussis vaccine was given, but 0·1 ml of a normal saline-
Freund's adjuvant emulsion was injected in place of the thyroid/adjuvant-emulsion. 
Treatment schedule 
There were six groups of test animals (Table I), which received intraperitoneal therapeutic 
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or control injections, commencing at the time of thyroid sensitization (day 0). The treat-
ments were given on days 0, 2, 6, 10 and 15, in individual doses of 1 ml. 
Total white and lymphocyte counts were determined on tail vein blood before sensitiza-
tion or the institution of treatment, and on postimmunization days 1, 3,6,8,10 and 15. 
The rats were killed by bleeding out on day 17, and specimens of thyroid, spleen, lymph 
nodes and thymus were fixed in 10% neutral buffered formalin. The tissues were paraffin 
embedded, sections stained with haematoxylin and eosin, and microscopically examined 
without prior knowledge of the treatment. The degree of thyroiditis present was graded as 
follows: 0, normal thyroid gland; +, mild focal thyroiditis; + +, focal thyroiditis with 
minimal follicular destruction; + + +, diffuse extensive mononuclear cell infiltrate with 
accompanying follicular destruction. 
RESULTS 
Hael1latological changes 
The peripheral lymphocyte counts in Groups A (saline treatment), E (normal rabbit 
serum) and F (saline-adjuvant sensitization) showed an increase from days 3 to 8 with a 
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FIG. I. The peripheral lymphocyte count in the various groups of rats: Arrows indicate days of 
treatments. e, Saline treatment; 0, lymph node lymphocyte antiserum; 0, thymus lympho-
cyte antiserum; f'c, spleen lymphocyte antiserum; A, normal rabbit serum; ., no treatment. 
steady decline thereafter (Fig. 1). The animals given the different antisera, however, 111-
variably responded with a prompt and highly significant lymphopenia. 
The effect of therapy on thyroiditis 
When thyroid tissue was omitted from the sensitizing emulsion (Group F, Table 1), no 
lesions were seen in the thyroid glands of the treated animals. However, with inclusion of 
thyroid tissue, all ten animals treated with intraperitoneal saline had histological evidence of 
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FIG. 2. Thyroid gland from rat immunized with thyroid-adjuvant emulsion, pertussis vaccine. 
(a) Treated with a line ; there is a diffuse celIu.1ar infiltra tion of the gland with follicle destruc-
tion (+ + + thyroiditis). H & E, x 160. (b) Treated with thymus lymphoctye antiserum ; the 
appearances a re those of a norma l gland. H & E, x 160. 
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allergic thyroiditis (Fig. 2). The severity of the thyroiditis was + + + in five of these animals 
and the mean score for the ten was 2·2 plus. Similarly, five of the six rats treated with normal 
rabbit serum had thyroiditis, the mean plus score being 1·8. 
In contrast (Table 1) microscopic changes in the thyroid were almost totally avoided in the 
twenty-nine rats who were given intraperitoneal ALS of one kind or another. In the entire 
group a diagnosis of thyroiditis was made only once. In this animal, which was treated with 
antiserum raised with lymph node lymphocytes, the lesion consisted of two small foci of 
thyroiditis. 
The spleen, lymph nodes and thymuses from both control and treated animals showed no 
significant histological abnormalities. 
DISCUSSION 
Witebsky & Rose (1956) first produced experimental allergic thyroiditis in rabbits by im-
munization with extracts of thyroid tissue emulsified in Freund's complete adjuvant. Using 
their technique, and with various modifications, allergic thyroiditis has been produced in 
rats by a number of other workers (Jones & Roitt, 1961; Metzgar & Grace, 1961; Biorklund, 
1964). The deficiencies of these methods were that more than one immunization dose of 
thyroid-adjuvant emulsion was required, thyroid lesions were not uniformly produced and 
the thyroiditis was often relatively mild. Recently, Paterson & Drobish (1968) described in 
rats an improvement in results if a concentrated pertussis vaccine was administered simul-
taneously with the thyroid-adjuvant emulsion. They were able to produce thyroiditis with-
out fail, in a shorter time, and in a more severe form. The results in ALS untreated animals 
in our present investigations were similar to and confirmatory of those of Paterson & Drobish 
(1968). 
The value of ALS in preventing the onset of experimental autoimmune disease has been 
well established (James, 1967). The iatrogenic disorders which have been treated include 
allergic encephalomyelitis in guinea-pigs (Waksman, Arbouys & Amason, 1961; Leibowitz, 
Lessof & Kennedy, 1968), adjuvant disease in rats (Currey & Ziff, 1968), and allergic 
thyroiditis in rats (Kalden et al., 1968). In the present study the thyroiditis model was used 
as a means to assay the relative immunosuppressive activity of different kinds of ALS. Under 
the conditions of these experiments there appeared to be no difference in the efficacy of the 
antisera raised with lymph node, thymic or splenic lymphocytes. This finding was consistent 
with an earlier report from our laboratories in which the same three ALS products were 
tested for their ability to mitigate cardiac homograft rejection, and were shown to have 
equivalent potency (Ono et at., 1969). Although several other investigators have claimed to 
have produced a superior ALS with one kind or other of lymphoid tissue (Nagaya & Sieker, 
1965; Kubista, Hallenbeck & Shorter, 1967), such differences have not been detectable in 
either variety of our controlled experiments. 
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